Diabetes – Liraglutide
This appraisal specific report is a review of the Mixed Treatment Comparison (MTC) analysis provided by the manufacturer of liraglutide in response to the appraisal consultation document (ACD) (April 2010).
TA203 Liraglutide for the treatment of type 2 diabetes (October 2010)
Liraglutide for the treatment of type 2 diabetes (PDF, 577KB)
A world top-100 university
We're a world top-100 university renowned for the excellence, impact and distinctiveness of our research-led learning and teaching.